Results 131 to 140 of about 33,833,464 (200)

Polo-like kinase 1 promotes Cdc42-induced actin polymerization for asymmetric division in oocytes. [PDF]

Open Biol, 2023
Yuen WS, Zhang QH, Bourdais A, Adhikari D, Halet G, Carroll J.   +5 more
europepmc   +1 more source

A Mouse Model of Partial Pancreas Agenesis Induced by Polo-like kinase 1 Mutation. [PDF]

FASEB J
Chen X, Jia Z, Kuang S.
europepmc   +1 more source

Polo‑like kinase 1 selective inhibitor BI2536 (dihydropteridinone) disrupts centrosome homeostasis via ATM‑ERK cascade in adrenocortical carcinoma. [PDF]

Oncol Rep, 2023
Lin RC, Chao YY, Lien WC, Chang HC, Tsai SW, Wang CY.   +5 more
europepmc   +1 more source

Polo-Like Kinase 1 Expression in Colorectal Cancer: Association With RAS Mutations. [PDF]

Cancer Sci
Tanaka Y, Oki E, Nakanishi R, Kawazoe T, Kudo K, Zaitsu Y, Hisamatsu Y, Ando K, Oda Y, Yoshizumi T.   +9 more
europepmc   +1 more source

Structural Basis for Variations in Polo-like Kinase 1 Conformation and Intracellular Stability Induced by ATP-Competitive and Novel Noncompetitive Abbapolin Inhibitors. [PDF]

ACS Chem Biol, 2023
Chapagai D, Merhej G, McInnes C, Wyatt MD.   +3 more
europepmc   +1 more source

Polo-like kinase 1 maintains transcription and chromosomal accessibility during mitosis. [PDF]

Mol Biol Cell
Shen Z, Adams K, Moreno R, F Lera R, Kaufman E, Lang JD, E Burkard M.   +6 more
europepmc   +1 more source

Polo-like kinase 1 is related with malignant characteristics and inhibits macrophages infiltration in glioma. [PDF]

Front Immunol, 2022
Luo L, Zhang XY, Zhen YW, Guo GC, Peng DZ, Wei C, Pei DL, Yu B, Ji YC, Liu XZ, Han L, Zhang ZY.   +11 more
europepmc   +1 more source

Polo-like kinase 1-inhibitor co-complex structures via the surface-entropy reduction approach and a DARPin-assisted approach. [PDF]

Acta Crystallogr D Struct Biol
Eberspaecher U, Schmitz AA, Siemeister G, Bömer U, Bandeiras TM, Matias PM, Schulze VK, Hillig RC.   +7 more
europepmc   +1 more source

Target Binding of Black Phosphorus Nanomaterial to Polo-Like Kinase 1 for Cancer Chemotherapy: A Mutual Selection of Nanomaterial and Protein. [PDF]

Exploration (Beijing)
Liu F, Li ZD, Zeng Y, Wang X, Liu Y, Li Q, Luo W, Suo X, Xu Y, Yuan F, Zhang D, Zhang W, Geng S, Yu XF, Zhang G, Li Y.   +15 more
europepmc   +1 more source

Polo-like kinase 1 (PLK1) O-GlcNAcylation is essential for dividing mammalian cells and inhibits uterine carcinoma. [PDF]

J Biol Chem, 2023
Yan S, Peng B, Kan S, Shao G, Xiahou Z, Tang X, Chen YX, Dong MQ, Liu X, Xu X, Li J.   +10 more
europepmc   +1 more source